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Intracellular photosensitiser localisation significantly influences the mechanism of response to photodynamic therapy (PDT), since the
primary sites of damage are closely related to the specific sensitiser distribution. Foscan
s subcellular localisation in the MCF-7 human
adenocarcinoma cell line has been studied by means of confocal microscopy and microspectrofluorometry. The fluorescence
topographic profiles recorded after cells costained with Foscan
s and organelle-specific fluorescent probes revealed that Foscan
s
presents low localisation in lysosomes and a weak accumulation in mitochondria. Alternatively, the Foscan
s fluorescence topographic
profile turned out to colocalise perfectly with that obtained for the endoplasmic reticulum (ER) and the Golgi apparatus. The patterns
of fluorescence derived from confocal microscopy studies were consistent with predominant localisation of Foscan
s in these
organelles. Furthermore, evaluation of enzymatic activity of selected organelles immediately after laser light irradiation (650 nm)
indicated the Golgi apparatus and ER as the primary damaged sites resulting from Foscan
s-mediated PDT in the MCF-7 cell line. To
our knowledge, this is the first study to demonstrate unambiguously that the ER and the Golgi apparatus are preferential sites of
Foscan
s accumulation.
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Photodynamic therapy (PDT) is a local treatment used for the
eradication of light-accessible solid tumours. This therapy is based
upon the systemic or local administration of photosensitising
compound followed by illumination with visible or near-infrared
light (Henderson and Dougherty, 1992). The photosensitiser
absorbs light and in the presence of oxygen transfers energy,
producing short-lived cytotoxic oxygen species such as singlet
oxygen or other oxygen radicals (Sharman et al, 2000). The
ultimate phototoxic effect of photosensitisers is governed by their
photophysical properties as well as their intratumoural and
intracellular uptake with subsequent translocation to various
membrane-delimited compartments. Since singlet oxygen, the
main cytotoxic species produced by PDT, is not able to diffuse over
distances longer than 10–20nm during its excited state lifetime
and cell dimensions are approximately 20mm, the primary sites of
photodynamic action should be strictly related to the specific
intracellular sensitiser distribution (Moan and Berg, 1991). Still,
the correlation between the sites of specific sensitiser localisation
and primary light-induced damage sites should be established for
every given photosensitiser.
Meta-tetra(hydroxyphenyl)chlorin (mTHPC, Foscan
s)i sa
second-generation photosensitiser (Bonnett et al, 1989) that
appears to be one of the most effective sensitisers studied to date
(Dougherty et al, 1998). Recently, a regulatory approval was
granted for the Foscan
s-PDT palliative treatment of head and
neck cancers. Clinical trials for other neoplastic diseases are
currently in an advanced stage (Ris et al, 1996; Baas et al, 2001;
Wyss et al, 2001). Despite numerous studies on Foscan
s’s
mechanisms of action, an enigma still persists regarding the
reason(s) for the high photodynamic efficiency of this sensitiser.
Its photophysical properties, such as quantum yields of triplet state
and singlet oxygen generation (Bonnett et al, 1999), are compar-
able or even inferior to other clinically relevant photosensitisers
(Blum and Grossweiner, 1985; Aveline et al, 1994). Another factor
determining the effective outcome of Foscan
s photosensitisation
could be its intracellular localisation. Two recent studies from our
group, performed using fluorescence microscopy, addressed the
intracellular localisation of Foscan
s in HT29 and MCF-7 cultured
cells (Melnikova et al, 1999; Teiten et al, 2001). In both cell lines we
noted diffuse intracellular distribution in the cytoplasm outside
the nucleus with intense fluorescence in the perinuclear region,
where the nuclear membrane and the Golgi/endoplasmic reticulum
(ER) complex are located. Our observations were consistent with
those from other groups (Ma et al, 1994; Hornung et al, 1997; Yow
et al, 2000). At present, no preferential subcellular target of
Foscan
s has been identified.
The microspectrofluorometry technique allows the investigation
of fluorescence in real time in localised cellular compartments
(Santus et al, 1991; Morlie `re et al, 1998; Matroule et al, 1999).
Spectral and topographic information available from areas smaller
than 1mm
2 make it possible to characterise fairly specific sites of
localisation and to follow the chronology of the photosensitised
reactions induced by specific probes.
Bearing this in mind, we performed a detailed analysis of
Foscan
s in vitro subcellular distribution in MCF-7 human breast Revised 12 July 2002; accepted 30 August 2002
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sadenocarcinoma cell line by means of microspectrofluorometry
and confocal laser scanning microscopy. We further attempted to
identify the primary photoinactivation sites through the study of
the enzymatic activities of selected organelles.
MATERIALS AND METHODS
Chemicals
Foscan
s was kindly supplied by Biolitec Pharma Ltd (Edinburgh,
UK). Foscan
s stock solution was prepared in methanol. Further
dilution was performed in phenol-red-free RPMI 1640 medium
(Life Technologies, Cergy-Pontoise, France) supplemented with
2% fetal calf serum (FCS, Dutscher, Brumath, France) to reach a
final concentration of 1mgm l
 1 (1.5mm) Foscan
s. The fluores-
cence probes used for staining the Golgi apparatus (N-(4,4-
difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-pentanoyl)
sphingosine, BODIPY
s FL C5-ceramide, BPC) and the ER (3,30-
dihexyloxacarbocyanine iodide, DiOC6) were purchased from
Molecular Probes-Europe (Leiden, The Netherlands). The probes
used for staining mitochondria (rhodamine 123, Rh123) and
lysosomes (lucifer yellow, LY) were provided by Sigma (Sigma-
Aldrich, France).
Treatment of cells prior to microspectrofluorometry and
confocal laser scanning microscopy
The MCF-7 human breast adenocarcinoma cell line was cultivated
in phenol-red-free RPMI 1640 medium supplemented with 9%
FCS, penicillin (10000IU) and streptomycin (10000IU). Exponen-
tially growing MCF-7 cells (1 10
4cellsml
 1) were plated in 2ml
of culture medium as monolayers in 35-mm Nunc Petri dishes
containing a microscope slide for microspectrofluorometric
analysis or in chambered coverglass (Nunc, Polylabo) for confocal
laser scanning microscopy (CLSM) observations. Cells were
incubated with 1mgml
 1 Foscan
s for 3h, and unless otherwise
indicated, washed with phosphate-buffered saline (PBS) and
incubated with a series of fluorescent probes to determine the
identity of subcellular organelles targeted by Foscan
s. For
lysosomes identification, cells were incubated overnight with
125mgm l
 1 LY, washed and incubated for 3h with 1mgm l
 1
Foscan
s (Haugland, 1996).
Rh123 was used at a final concentration of 10mm for 45min to
identify mitochondria with microspectrofluorometry and at a
concentration of 5mm for 30min, with CLSM (Kim et al, 1998).
These concentration and incubation conditions are optimal for the
specific staining of mitochondria in carcinoma-derived cell lines,
including MCF-7 (Nadakavukaren et al, 1985). To visualise the
Golgi apparatus, cells were labelled with 4mm BPC for 15min
(Pagano et al, 1991). The ER was labeled with the lipophilic,
cationic DiOC6 dye applied for 15min at a final concentration of
2mgml
 1 (Terasaki et al, 1984). This marker, used in the
concentration range 1–10mgml
 1, was reported to be highly
specific for ER and, compared to other possible candidates, is
brightest with the slowest bleaching rate (Sabnis et al, 1997). At the
end of the double staining, the labelling solution was removed by
gentle rinsing with RPMI 1640 containing 25mm Hepes, and
microspectrofluorometry measurements or observations by con-
focal fluorescence microscopy were performed.
Confocal laser scanning microscopy
The cells double stained with Foscan
s and organelle probes were
examined with a confocal laser scanning microscope (ASP-2 AOBS
CLSM, Leica microsystem, Germany) equipped with a  63,
numerical aperture 1.3 oil immersion objective (Leica, Germany).
A pinhole of 60.85mm was used and each image recorded
contained 512 512 pixels. An He/Ne laser was used as excitation
light at 458nm for all organelle probes and at 633nm for Foscan
s.
Fluorescence of the organelles probes was detected on channel 1
with a 505–545nm band pass (BP) emission filter. Channel 2 was
used to detect the red fluorescence of Foscan
s with a 640–660nm
BP emission filter. The fluorescence images were displayed in
green and red ‘false’ colour output and electronically combined to
visualise colocalisation in yellow. Controls (cells stained only with
Foscan
s or organelle probes) were conducted in parallel to
optimise the staining protocol and the detecting parameters of
CLSM.
Microspectrofluorometric techniques
The microspectrofluorometer used is centred around a Leitz
‘Diavert’ inverted microscope and has been described previously
(Morlie `re et al, 1998). Fluorescence was excited over the whole
microscopic field through the objective lens ( 40,  63 and
 100) with 435nm light from an OSRAM HBO 100W mercury
lamp. A slit in the primary image plane, which delineates a 1.5mm
area in the microscopic field from which the fluorescence can be
collected, is used as an entrance slit of a 150grooves mm
 1 grating
and provides 5nm spectral resolution. Fluorescence photons
received by a two-dimensional, cooled charge-coupled device
target produce a ‘spectrotopographic image’. Such images can be
interpreted as either a succession in the X-direction of linear,
monochromatic images of a 1.5mm wide strip or a succession of
spectra along the Y-axis, each corresponding to an area
1.5 0.21mm( 40 objective), 1.5 0.135mm( 63 objective) or
1.5 0.085mm( 100 objective) of the strip.
Enzymatic activity measurements
Logarithmically growing MCF-7 cells were incubated with
1mgm l
 1 Foscan
s over 3h. At the end of the incubation period,
cells were washed three times, reincubated in fresh culture medium
and irradiated with a 650nm laser diode light (Coherent, France)
at a fluence rate of 2.12mWcm
 2 for different light doses.
Immediately after irradiation, cytotoxicity was determined by
clonogenic assay as previously described (Merlin et al, 1992).
Colonies composed of more than 50 cells were counted 14 days
later with an automatic image analysis program (AnalySiS 3.1).
The effect of PDT on the activity of enzymes located in different
cellular compartments was evaluated immediately after 180s of
light exposure corresponding to 0.74Jcm
 2. At this light fluence,
99% of the cells were inhibited from forming colonies (lethal dose
99%, LD99).
For the determination of cytochrome c oxidase activity, the
mitochondria were isolated from cells. The enzymatic activity was
then measured as described by Gibson and Hilf (1983) by a
spectrophotometric technique recording the disappearance of
cytochrome cred (reduced form of the substrate cytochrome c
(Sigma) at 550nm).
The UDP galactosyl transferase activity was measured from
extracts of microsomes as described by Brandli et al (1988). This
method is based on the ability of this enzyme to bind the
radioactive-labelled uridine diphospho-d-galactose (Amersham,
France), to ovalbumin, which can be monitored by scintillation
counting of the radioactivity with a Beckman automatic liquid
scintillation system.
The NADPH cytochrome c reductase activity was measured
from extracts of microsomes as described by Beaufay et al (1974).
This method is based on the formation of the reduced form of
cytochrome c, cytochrome cred, induced by NADPH, which can be
recorded spectrophotochemically at 550nm.
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sRESULTS
Intracellular Foscan
s localisation assessed by confocal
laser scanning microscopy
Confocal micrographs of the double-stained MCF-7 cells with
Foscan
s and the organelle markers are presented in Figure 1. The
representative images of Foscan
s are shown in red (left panel), the
organelle-specific dyes in green (middle panel), and the overlapped
images in yellow (right panel).
Foscan
s presents an intracellular fluorescence distribution in
cytoplasmic compartments with no obvious fluorescence in the
nucleus (Figure 1). Subcellular localisation was further examined
using costaining with organelle probes. Figure 1 (row a) shows that
the staining patterns of lysosomal probe LY and Foscan
s were
different, thus indicating that very little Foscan
s accumulated
inside the lysosomes. The mitochondrial image showed a partial
overlap with the corresponding Foscan
s image (Figure 1, row b).
The Golgi probe BPC requires special attention. Two wave-
lengths of emission should be considered for this probe.
Figure 1 Confocal fluorescence images of MCF-7 cells double stained with Foscan
s and organelle probes. Lysosomes were stained by overnight
incubation with 125mgm l
 1 LY, washed and incubated for 3h with 1mgm l
 1 Foscan
s (row A). For other organelle probes, cells were sensitised with
Foscan
s (1mgm l
 1, 3h), washed and then subjected to organelle staining. Mitochondria were labeled with 5mM Rh123 for 30min (row B), Golgi apparatus
was stained with 4mM BPC (15min) (row C) and ER with 2mgm l
 1 DiOC6 for 15min (row D). Objective magnification 63.
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sIncorporation of BPC in the Golgi apparatus and in the Golgi
vesicles promotes the aggregation of the probe, which emits a red
fluorescence at 621nm. In the monomeric form, it binds to
intracellular membranes (e.g., the ER, nuclear envelope) and emits
a green fluorescence at 545nm. However, by detecting green
fluorescence, it was found that this dye accumulates also in a
region of intense green fluorescence identified as the Golgi body
(Pagano et al, 1991). Considering the red fluorescence of Foscan
s,
only a green fluorescence filter could be used to observe BPC in the
micrographs shown in Figure 1 (row C). A good superposition
between the Golgi dye image and that of Foscan
s was evident. This
was expected since both dyes, being lipophilic, have a preference
for the membranous organelles of the MCF-7 cells. The bright
fluorescence in the perinuclear region was presumed to be a Golgi
body. The presence of BPC aggregates will be addressed in the
topographic spectra analysis of Foscan
s intracellular localisation.
A clear colocalisation of Foscan
s and DiOC6 in the ER was
observed (Figure 1, row D).
Intracellular Foscan
s localisation assessed by
microspectrofluorometry
Figures 2–5 display the fluorescence spectra of the organelle
markers alone (panels a), the fluorescence spectra of Foscan
s and
the organelle markers (panels b), and the topographic profiles of
both compounds (panels c and d) from the single living cell. The
topographic profiles were recorded along a strip within the cell at
the specific emission wavelengths of Foscan
s and organelle
probes. It should be noted that the fluorescence emission of all
organelle probes was well separated from that of Foscan
s
(lem¼654nm).
Results of measurements performed after coincubation of cells
with Lucifer Yellow (LY), are presented in Figure 2. The
fluorescence topographic profile of Foscan
s did not match that
obtained with LY (lem¼550nm) as the spikes of LY fluorescence
at lysosomic locations did not overlap the red profile of Foscan
s
(Figure 2c). In other words, both lysosomes and cellular
compartments in the close vicinity that are devoid of lysosomes
were stained by Foscan
s in a similar mode.
Figure 3c shows the fluorescence topographic profiles of
Foscan
s and Rh123 (lem¼545nm). Both profiles exhibit quite a
similar tendency without the extensive overlap between them.
To evaluate the possible localisation of Foscan
s in the Golgi
apparatus/ER complex, Foscan
s-loaded cells were incubated with
BPC. Figure 4a shows that the fluorescence spectrum of BPC in
MCF-7 cells has two maxima, at 545 and 621nm. The red
fluorescence of BPC indicates aggregates formation in the
perinuclear areas, which correspond to Golgi apparatus (Pagano
et al, 1991). The fluorescence topographic profile of BPC, recorded
at 621nm, shows a good superposition with that of Foscan
s, thus
indicating their good colocalisation (Figure 4C). Even better
colocalisation was observed when BPC fluorescence was recorded
at 545nm (Figure 4D). In order to determine whether this latter
colocalisation pattern corresponds to Foscan
s accumulation in the
ER, cells were costained with DiOC6 (lem¼545nm). The plots of
Figure 5 demonstrate that the Foscan
s fluorescence topographic
profile turned out to colocalise perfectly with that obtained for
DiOC6. These data unambiguously indicate a good localisation of
Foscan
s in the ER and in the Golgi apparatus of MCF-7 cells.
Foscan
s sensitised photoinactivation of intracellular
enzymes
Despite the direct correlation between the sites of dye location and
sites of direct photodamage, the probability always exists that a
low level of incorporation into a given compartment may give rise
to a high impact of photochemical reaction. Therefore, in the next
step we addressed the immediate post-PDT damage of enzymes
known as markers for subcellular organelles.
The activity of the mitochondrial enzyme cytochrome c oxidase
was apparently not affected by Foscan
s photosensitisation, since
its activity was fully preserved in cells undergoing 99% death.
Under the same irradiation conditions, the enzymatic activity of
NADPH cytochrome c reductase associated with the ER was
reduced by 54.076.3%, while that of the UDP galactosyl
transferase located in the Golgi apparatus was reduced by
7875.25%.
DISCUSSION
The main goal of the present study was the identification of the
specific subcellular localisation of Foscan
s, as it yields valuable
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Figure 2 Intracellular fluorescence spectra of LY alone (A). Intracellular
fluorescence spectra (B) and fluorescence topographic profiles (C)o f
MCF-7 cells incubated overnight with 125mgml
 1 LY and Foscan
s
(1mgml
 1, 3h). The spectrum in (B) was recorded at position 16.6mmo n
the X-axis of the profile in (C). Fluorescence topographic profiles in (C)
were recorded at 550nm (LY) and at 654nm (Foscan
s). Excitation
wavelength 435nm, objective magnification 40, exposure time 4s.
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sinformation about the primary targets of Foscan
s-PDT. Correlat-
ing the sites of dye location and sites of direct photodamage seems
allowable since photochemically produced singlet oxygen is
expected to diffuse intracellularly to distances limited by its short
lifetime to 10–20nm (Moan and Berg, 1991).
Lysosomes have been shown to be a potential site of localisation
for aggregated and/or hydrophilic sensitizers (Ge `ze et al, 1993;
Berg and Moan, 1997). These organelles have been implicated in a
cell death mechanism mediated through the photoinduced
production of ceramide (Sawai and Hannun, 1999). The photo-
micrographs (Figure 1) and the fluorescence topographic profiles
(Figure 2) recorded in cells double stained with Foscan
s and LY
do not favour Foscan
s accumulation in lysosomes.
There is strong evidence that sensitisers with an acute
localisation in mitochondria promote the release of cytochrome c
upon irradiation (Xue et al, 2001). This loss of cytochrome c can be
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Figure 3 Intracellular fluorescence spectra of Rh123 alone (A). Intra-
cellular fluorescence spectra (B) and fluorescence topographic profiles (C)
of MCF-7 cells incubated for 3h with 1mgm l
 1 Foscan
s and then with
10mM Rh123 for 45min. The spectrum in (B) was recorded at position
13.5mm on the X-axis of the profile in (C). Fluorescence topographic
profiles in (C) were recorded at 545nm (Rh123) and at 654nm
(Foscan
s). Excitation wavelength 435nm, objective magnification 63,
exposure time 4s.
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Figure 4 Intracellular fluorescence spectra of BPC alone (A). Intracel-
lular fluorescence spectra (B) and fluorescence topographic profiles (C)o f
MCF-7 cells incubated for 3h with 1mgm l
 1 Foscan
s and then with 4mM
BPC during 15min. The spectrum in (B) was recorded at position 8.5mm
on the X-axis of the profiles in (C) and (D). Fluorescence topographic
profiles of Foscan
s (654nm) and BPC, recorded either at 621nm, which
corresponds to the Golgi apparatus (C), or at 545nm, which corresponds
to intracellular membranes (D). Excitation wavelength 435nm, objective
magnification 100, exposure time 4s.
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slethal to cells either because of the disruption of the mitochondrial
respiratory chain with the eventual reduction of cellular ATP levels
or through caspase initiation with subsequent apoptotic cell death
(Yow et al, 2000; Xue et al, 2001). Figure 3C shows that
mitochondrial-localising Rh123 and Foscan
s fluorescence topo-
graphic patterns were different, indicating a poor affinity of
Foscan
s for these organelles. This observation was consistent with
the photomicrograph of dual labeling of Foscan
s and Rh123
(Figure 1, row B).
The ER and the Golgi apparatus are closely linked not only by
their location in the perinuclear area of the cytoplasm, but also as
they interact together in the case of newly synthesised proteins.
The ER is known to play a central role in the biosynthesis,
segregation and transport of proteins and lipids as well as in the
release of intracellular stores of calcium (Terasaki et al, 1984). The
Golgi apparatus receives newly synthesised proteins from the ER
and modifies them chemically, for example, by glycosylation or
sulphonation (Short and Barr, 2000). The impact of PDT on the ER
and Golgi apparatus has not often been taken into account. Only a
few studies have demonstrated the importance of photochemical
damage to the Golgi apparatus and ER for the inactivation of
tumour cells in culture (Morlie `re et al, 1998; Matroule et al, 1999;
Fabris et al, 2001). Thus, photochemical damage to the ER has
been proposed to explain the exceptional effectiveness of
tolyporphin compared to other sensitisers (Morlie `re et al, 1998).
Recently, the Golgi apparatus was found to be a primary site of
photodamage in cells photosensitised with zinc (II) phthalo-
cyanine (Fabris et al, 2001).
From the photomicrographs of cells costained with Foscan
s and
BPC (Figure 1C), it appears rather difficult to deduce whether
Foscan
s localises in the Golgi complex, as the green fluorescence
of BPC is not specific for the Golgi body. The use of
microspectrofluorometry makes possible the identification of the
Golgi apparatus since the red fluorescence of the Golgi probe could
be well separated from that of Foscan
s (Figure 4). The comparison
of Foscan
s and BPC topographic profiles presented in Figure 4C,
D demonstrated a good localisation of Foscan
s in the Golgi
apparatus and even better colocalisation when BPC’s green
fluorescence was registered, pointing out the staining of different
intracellular membranes including that of the ER. Foscan
s’s
localisation in the ER was further unambiguously confirmed by the
Foscan
s/DiOC6 double staining assessed by confocal microscopy
and microspectrofluorometry (Figures 1 and 5). In particular,
Figure 5C demonstrates a perfect colocalisation of Foscan
s and
DiOC6 fluorescence topographic profiles.
Photosensitised damage to enzymes characteristic of subcellular
organelles gives information about the intracellular localisation of
the sensitiser and could be indicative of the primary photodamage
sites (Rodal et al, 1998; Fabris et al, 2001). The measurements of
the enzymatic activities of selected organelles after Foscan
s
photosensitisation reinforce the conclusion of the predominant
localisation of Foscan
s in the ER and Golgi apparatus. The lack of
inactivation of the mitochondrial marker enzyme cytochrome c
oxidase in cells undergoing almost complete photokilling indicates
low mitochondrial localisation of Foscan
s. This observation does
not exclude the possibility that Foscan
s molecules accumulated in
mitochondrial sites remote from the marker enzyme investigated
and toward which singlet oxygen could not easily diffuse.
Meantime, the activities of NADPH cytochrome c reductase, which
localises in the ER, and UDP galactosyl transferase, a marker
enzyme for the Golgi apparatus, were significantly decreased in
cells immediately after Foscan
s-based PDT. It is worth noting that
Foscan
s localisation in the endoplasmic reticulum led to only
partial (54%) inhibition of NADPH cytochrome c reductase
activity, whereas much better correlation appears between the
extent of inhibition of UDP galactosyl transferase activity and
Foscan
s photosensitised cell inactivation. Further experiments are
required before any detailed explanation can be evoked.
In conclusion, the present study, which is based primarily on the
microspectrofluorometric analysis of cells costained with Foscan
s
and organelle-specific probes, has clearly shown that Foscan
s
exhibits low or no localisation in lysosomes and only a weak
accumulation in mitochondria. It has been unambiguously
demonstrated that the Golgi apparatus and ER are preferential
sites of Foscan
s accumulation. To our knowledge, this is the first
study to verify Foscan
s localisation in these organelles. Further-
more, measurements of subcellular marker enzyme photoinactiva-
tion may indicate the Golgi apparatus and ER as the primary
therapy-induced damage sites resulting from Foscan
s-mediated
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Figure 5 Intracellular fluorescence spectra of DiOC6 alone (A). Intra-
cellular fluorescence spectra (B) and fluorescence topographic profiles (C)
of MCF-7 cells incubated for 3h with 1mgm l
 1 Foscan
s and then with
2mgm l
 1 DiOC6 for 15min. The spectrum in (B) was recorded at
position 5.70mm on the X-axis of the profile in (C). Fluorescence
topographic profiles in (C) were recorded at 545nm (DiOC6) and at
654nm (Foscan
s). Excitation wavelength 435nm, objective
magnification 100, exposure time 4s.
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sPDT in the MCF-7 cell line. The final identification of the
intracellular sites crucial for photoinactivation could be done
through establishing the causal relation between the damage
brought to certain organelles and overall cytotoxicity.
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